Tag #Sleep Apnea

Showing 1 to 11 of 11 results

repubblica.it

🌐 75% Global Worthiness

Jun 8, 16:12

Italian Snoring Epidemic Costs €31 Billion Annually

In Italy, over 24 million people (54% of the 15-74 age group) suffer from snoring, costing the nation €31 billion annually. The newly formed Italian Academy of Roncology aims to improve diagnosis and treatment of sleep apnea, a serious condition linked to snoring, which is estimated to affect nearly...

Italian Snoring Epidemic Costs €31 Billion Annually

In Italy, over 24 million people (54% of the 15-74 age group) suffer from snoring, costing the nation €31 billion annually. The newly formed Italian Academy of Roncology aims to improve diagnosis and treatment of sleep apnea, a serious condition linked to snoring, which is estimated to affect nearly...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate health and economic impact of snoring in Italy?

In Italy, 54% of the 15-74 age group (over 24 million people) experience snoring, a health issue with potentially serious consequences. This is not trivial; addressing it can prevent significant diseases. A new medical discipline, roncology, studies snoring dynamics and their effects on various organs.

zeit.de

🌐 65% Global Worthiness

May 21, 22:10

Mouth Taping for Sleep Apnea: Limited Evidence, Significant Risks

A Canadian study of 213 participants across ten trials found limited evidence supporting mouth taping for sleep apnea; risks outweigh benefits, particularly for those with nasal congestion, highlighting the need for larger, better studies.

Mouth Taping for Sleep Apnea: Limited Evidence, Significant Risks

A Canadian study of 213 participants across ten trials found limited evidence supporting mouth taping for sleep apnea; risks outweigh benefits, particularly for those with nasal congestion, highlighting the need for larger, better studies.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential risks associated with mouth taping, particularly for individuals with pre-existing nasal conditions?

Mouth taping's popularity, fueled by celebrity endorsements, contrasts with the weak scientific evidence supporting its efficacy. While some studies hinted at potential benefits for mild sleep apnea, the overall low quality of the data and the identified risks—particularly oxygen deprivation in individuals with nasal obstruction—preclude a recommendation for those with sleep-related breathing disorders. The risk of aspiration is another factor.

kathimerini.gr

🌐 85% Global Worthiness

Feb 26, 10:09

GLP-1 Agonist Shows Significant Promise in Treating Obstructive Sleep Apnea

A year-long study published in The New England Journal of Medicine showed that tirzepatide, a GLP-1 agonist, reduced the apnea-hypopnea index by almost 59% in 469 obese individuals with moderate-to-severe obstructive sleep apnea, alongside an average 20% weight loss; this may reduce reliance on CPAP...

GLP-1 Agonist Shows Significant Promise in Treating Obstructive Sleep Apnea

A year-long study published in The New England Journal of Medicine showed that tirzepatide, a GLP-1 agonist, reduced the apnea-hypopnea index by almost 59% in 469 obese individuals with moderate-to-severe obstructive sleep apnea, alongside an average 20% weight loss; this may reduce reliance on CPAP...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the key mechanisms by which GLP-1 agonists impact obstructive sleep apnea, and what factors contribute to its varying effectiveness among individuals?

This significant reduction in OSA severity is linked to weight loss induced by GLP-1 agonists. Excess weight is a major risk factor for OSA, as fat deposits in the neck and abdomen restrict airways. The study, published in The New England Journal of Medicine, involved 469 obese participants with moderate to severe OSA.

cnn.com

🌐 85% Global Worthiness

Dec 21, 01:08

FDA Approves First Prescription Drug for Obstructive Sleep Apnea

The FDA approved Zepbound, a GLP-1 receptor agonist, as the first prescription drug for moderate-to-severe obstructive sleep apnea in obese patients; clinical trials showed significant improvements in breathing disruptions and weight loss (18-20%), potentially impacting the 30 million Americans with...

FDA Approves First Prescription Drug for Obstructive Sleep Apnea

The FDA approved Zepbound, a GLP-1 receptor agonist, as the first prescription drug for moderate-to-severe obstructive sleep apnea in obese patients; clinical trials showed significant improvements in breathing disruptions and weight loss (18-20%), potentially impacting the 30 million Americans with...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the FDA's approval of Zepbound for treating obstructive sleep apnea?

The FDA approved Zepbound, a weight-loss drug, as the first prescription medicine for moderate-to-severe obstructive sleep apnea (OSA) in obese individuals. This approval, coupled with a reduced-calorie diet and increased physical activity, offers a new treatment option for the estimated 30 million Americans with OSA. The drug's effectiveness was demonstrated in clinical trials, showing significant reductions in breathing disruptions and weight loss.

forbes.com

🌐 85% Global Worthiness

Dec 21, 01:08

FDA Approves First Prescription Sleep Apnea Drug: Zepbound

The Food and Drug Administration (FDA) approved Zepbound, a drug previously approved for weight loss, as the first prescription medication to treat sleep apnea, affecting an estimated 39 million American adults.

FDA Approves First Prescription Sleep Apnea Drug: Zepbound

The Food and Drug Administration (FDA) approved Zepbound, a drug previously approved for weight loss, as the first prescription medication to treat sleep apnea, affecting an estimated 39 million American adults.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of the FDA's approval of Zepbound for treating sleep apnea?

The FDA approved Zepbound, a GLP-1 receptor agonist, as the first prescription treatment for sleep apnea. This approval follows its authorization last year for weight loss, marking a significant achievement for Eli Lilly. Approximately 39 million American adults suffer from obstructive sleep apnea, highlighting the potential impact of this new treatment.

sueddeutsche.de

🌐 85% Global Worthiness

Dec 18, 19:11

Philips Faces Italian Class-Action Lawsuit Over Faulty Medical Devices

A class-action lawsuit against Philips in Italy targets 5.5 million potentially harmful ventilators and sleep therapy devices containing faulty foam, with over 30,000 registrants seeking compensation; while a US settlement reached $1.1 billion, the EU cases face different legal hurdles to prove harm...

Philips Faces Italian Class-Action Lawsuit Over Faulty Medical Devices

A class-action lawsuit against Philips in Italy targets 5.5 million potentially harmful ventilators and sleep therapy devices containing faulty foam, with over 30,000 registrants seeking compensation; while a US settlement reached $1.1 billion, the EU cases face different legal hurdles to prove harm...

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of the Philips class-action lawsuit in Italy for affected patients and the company?

Philips faces a class-action lawsuit in Italy over potentially harmful ventilators and sleep therapy devices. Over 5.5 million devices worldwide contained faulty foam that could break down into particles, inhalable by users. More than 30,000 individuals have registered for the Italian lawsuit, seeking compensation between €500 and €50,000.

bbc.com

🌐 75% Global Worthiness

Jun 4, 16:14

Nasal Breathing: A 'Superpower' for Improved Health and Well-being

A BBC News journalist recounts their experience with nasal surgery, revealing significant improvements in allergies, sleep, and mental health after correcting a deviated septum, highlighting the often-overlooked importance of nasal breathing and exploring the controversial use of mouth tape as a rem...

Nasal Breathing: A 'Superpower' for Improved Health and Well-being

A BBC News journalist recounts their experience with nasal surgery, revealing significant improvements in allergies, sleep, and mental health after correcting a deviated septum, highlighting the often-overlooked importance of nasal breathing and exploring the controversial use of mouth tape as a rem...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the natural filtration system of the nose contribute to overall health, and what are the consequences of mouth breathing?

The article connects improved nasal breathing to several health benefits. By correcting a deviated septum, the author experienced better sleep, reduced allergies, and improved mental clarity. Experts cited in the article emphasize the nasal passages' role as a natural filter, protecting the body from pollutants and improving immune function.

bbc.com

🌐 65% Global Worthiness

May 10, 16:11

Nasal Breathing's Impact on Health and Well-being: A Personal Account

A BBC journalist details his experience undergoing surgery for a deviated septum, highlighting the significant impact of nasal breathing on health, including improved sleep quality and reduced sleep apnea symptoms, and the potential benefits of nasal breathing for mental well-being.

Nasal Breathing's Impact on Health and Well-being: A Personal Account

A BBC journalist details his experience undergoing surgery for a deviated septum, highlighting the significant impact of nasal breathing on health, including improved sleep quality and reduced sleep apnea symptoms, and the potential benefits of nasal breathing for mental well-being.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the structure and function of the nasal passages impact respiratory health and overall well-being?

The journalist's experience underscores the crucial role of nasal breathing in health. Nasal passages filter air, warming and humidifying it before it reaches the lungs; bypassing this process through mouth breathing increases risks of infections and dental issues. The article further connects nasal breathing to mental well-being, linking it to reduced anxiety and improved brain function.

dutchnews.nl

🌐 85% Global Worthiness

Feb 7, 13:10

Philips Faces €800 Million Lawsuit Over Sleep Apnea Scandal

Over 100 institutional investors are demanding €800 million from Philips for concealing sleep apnea device health risks for a decade, causing €28 billion in market capitalization loss and prompting multiple recalls, despite Philips denying any wrongdoing.

Philips Faces €800 Million Lawsuit Over Sleep Apnea Scandal

Over 100 institutional investors are demanding €800 million from Philips for concealing sleep apnea device health risks for a decade, causing €28 billion in market capitalization loss and prompting multiple recalls, despite Philips denying any wrongdoing.

Progress

44% Bias Score

ShareSaveArticle

Responsible Consumption and Production

12345678

Previous 1 of 8 Next

How did Philips's alleged actions regarding the sleep apnea devices contribute to the significant losses incurred by shareholders?

The investors' claim highlights a failure of corporate transparency and accountability. Philips's alleged delay in disclosing health risks associated with its sleep apnea devices led to substantial financial losses for shareholders. This case underscores the importance of timely and accurate disclosures in maintaining investor confidence and market integrity.

cnbc.com

🌐 85% Global Worthiness

Dec 21, 01:08

FDA Approves Zepbound for Obstructive Sleep Apnea

The FDA approved Eli Lilly's Zepbound for treating obstructive sleep apnea (OSA), expanding its use beyond obesity; clinical trials showed 43-51.5% disease resolution in patients compared to 13.6-14.9% with placebo, potentially impacting 80 million Americans with OSA.

FDA Approves Zepbound for Obstructive Sleep Apnea

The FDA approved Eli Lilly's Zepbound for treating obstructive sleep apnea (OSA), expanding its use beyond obesity; clinical trials showed 43-51.5% disease resolution in patients compared to 13.6-14.9% with placebo, potentially impacting 80 million Americans with OSA.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of the FDA's approval of Zepbound for treating obstructive sleep apnea?

The FDA approved Eli Lilly's Zepbound for treating obstructive sleep apnea (OSA), a condition affecting 80 million Americans. This makes Zepbound the first drug treatment for OSA in combination with diet and exercise. Eli Lilly plans to launch this expanded use early next year.

npr.org

🌐 85% Global Worthiness

Dec 21, 22:08

FDA Approves Zepbound for Obstructive Sleep Apnea Treatment

The FDA approved Eli Lilly's Zepbound (tirzepatide) as the first medication to treat obstructive sleep apnea in obese adults, following two successful 52-week studies demonstrating significant symptom reduction.

FDA Approves Zepbound for Obstructive Sleep Apnea Treatment

The FDA approved Eli Lilly's Zepbound (tirzepatide) as the first medication to treat obstructive sleep apnea in obese adults, following two successful 52-week studies demonstrating significant symptom reduction.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of the FDA's approval of Zepbound for treating obstructive sleep apnea?

The FDA approved Zepbound, a weight-loss drug, as the first treatment for obstructive sleep apnea (OSA) in obese adults. Two 52-week studies showed Zepbound significantly reduced apnea symptoms, regardless of CPAP machine use.

Showing 1 to 11 of 11 results